Literature DB >> 8777457

Toxicokinetics of 2,4- and 2,6-toluenediamine in hydrolysed urine and plasma after occupational exposure to 2,4- and 2,6- toluene diisocyanate.

P Lind1, M Dalene, G Skarping, L Hagmar.   

Abstract

OBJECTIVES: To assess the toxicokinetics of 2,4- and 2,6- toluenediisocyanate (TDI) in chronically exposed subjects.
METHODS: Blood and urine, from 11 workers at two flexible foam polyurethane production plants, were sampled. By gas chromatography-mass spectrometry (GC-MS) 2,4- and 2,6-toluene diamine (TDA) were measured as pentafluoropropionic anhydride (PFPA) derivatives after acidic hydrolysis of plasma (P-TDA, ng/ml) and urine (U-TDA, microgram/h).
RESULTS: In one of the plants the P-2,4-TDA concentrations were 0.4-1 ng/ml before a four to five week holiday and 0.2-0.5 ng/ml afterwards. The corresponding values for P-2,6-TDA were 2-6 and 0.5-2 ng/ml respectively. In the other plant the P-2,4-TDA concentrations were 2-23 ng/ml before the holiday and 0.5-6 ng/ml afterwards and the P-2,6-TDA concentrations were 7-24 ng/ml before and 3-6 ng/ml afterwards. The P-2,4-TDA concentrations were 2-24 ng/ml before a 12 day holiday, and 1-14 ng/ml afterwards. The corresponding values for P-2,6-TDA were 12-29 and 8-17 ng/ml, respectively. The urinary elimination rates (U-TDA, microgram/h) for 2,4-TDA before the holiday were 0.04-0.54 and 0.02-0.18 microgram/h afterwards. The corresponding values for 2,6-TDA were 0.18-0.76 microgram/h before and 0.09-0.27 microgram/h after the holiday. The half life in urine ranged between 5.8 and 11 days for 2,4- and 2,6-TDA. The differences in exposure were reflected by the P-TDA concentrations. The mean half life in plasma was 21 (range 14-34) days for 2,4-TDA and 21 (16-26) days for 2,6-TDA. The TDI air concentrations varied between 0.4 and 4 micrograms/m3 in one plant and in the other between 10 and 120 micrograms/m3.
CONCLUSIONS: The half life in plasma of chronically exposed workers for 2,4-and 2,6-TDA was twice as long as for volunteers with short term exposure. An indication of a two phase elimination pattern in urine was found. The first phase was related to the more recent exposure and the second, much slower one was probably related to release of TDA in urine from TDI adducts in the body.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8777457      PMCID: PMC1128420          DOI: 10.1136/oem.53.2.94

Source DB:  PubMed          Journal:  Occup Environ Med        ISSN: 1351-0711            Impact factor:   4.402


  12 in total

Review 1.  Isocyanate-induced respiratory disease.

Authors:  D E Banks; B T Butcher; J E Salvaggio
Journal:  Ann Allergy       Date:  1986-12

2.  Biological monitoring of isocyanates and related amines. IV. 2,4- and 2,6-toluenediamine in hydrolysed plasma and urine after test-chamber exposure of humans to 2,4- and 2,6-toluene diisocyanate.

Authors:  T Brorson; G Skarping; C Sangö
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

3.  Specific serum antibodies against isocyanates: association with occupational asthma.

Authors:  A Cartier; L Grammer; J L Malo; F Lagier; H Ghezzo; K Harris; R Patterson
Journal:  J Allergy Clin Immunol       Date:  1989-10       Impact factor: 10.793

Review 4.  Clinical features and epidemiology of occupational obstructive respiratory disease caused by small molecular weight organic chemicals.

Authors:  L Hagmar; J Nielsen; S Skerfving
Journal:  Monogr Allergy       Date:  1987

5.  Incidence of cancer and exposure to toluene diisocyanate and methylene diphenyldiisocyanate: a cohort based case-referent study in the polyurethane foam manufacturing industry.

Authors:  L Hagmar; U Strömberg; H Welinder; Z Mikoczy
Journal:  Br J Ind Med       Date:  1993-11

6.  Mortality and cancer morbidity of production workers in the United Kingdom flexible polyurethane foam industry.

Authors:  T Sorahan; D Pope
Journal:  Br J Ind Med       Date:  1993-06

7.  Determination of toluenediamine isomers by capillary gas chromatography and chemical ionization mass spectrometry with special reference to the biological monitoring of 2,4- and 2,6-toluene diisocyanate.

Authors:  G Skarping; M Dalene; P Lind
Journal:  J Chromatogr A       Date:  1994-03-11       Impact factor: 4.759

8.  Cancer incidence and mortality in the Swedish polyurethane foam manufacturing industry.

Authors:  L Hagmar; H Welinder; Z Mikoczy
Journal:  Br J Ind Med       Date:  1993-06

9.  Biological monitoring of isocyanates and related amines. III. Test chamber exposure of humans to toluene diisocyanate.

Authors:  G Skarping; T Brorson; C Sangö
Journal:  Int Arch Occup Environ Health       Date:  1991       Impact factor: 3.015

10.  Biological monitoring of occupational exposure to toluene diisocyanate.

Authors:  A Maître; M Berode; A Perdrix; S Romazini; H Savolainen
Journal:  Int Arch Occup Environ Health       Date:  1993       Impact factor: 3.015

View more
  6 in total

1.  Urine 1,6-hexamethylene diamine (HDA) levels among workers exposed to 1,6-hexamethylene diisocyanate (HDI).

Authors:  Linda G T Gaines; Kenneth W Fent; Sheila L Flack; Jennifer M Thomasen; Louise M Ball; David B Richardson; Kai Ding; Stephen G Whittaker; Leena A Nylander-French
Journal:  Ann Occup Hyg       Date:  2010-06-07

2.  Dermal, inhalation, and internal exposure to 1,6-HDI and its oligomers in car body repair shop workers and industrial spray painters.

Authors:  A Pronk; F Yu; J Vlaanderen; E Tielemans; L Preller; I Bobeldijk; J A Deddens; U Latza; X Baur; D Heederik
Journal:  Occup Environ Med       Date:  2006-05-25       Impact factor: 4.402

3.  Biological monitoring to assess exposure from use of isocyanates in motor vehicle repair.

Authors:  N R Williams; K Jones; J Cocker
Journal:  Occup Environ Med       Date:  1999-09       Impact factor: 4.402

4.  Biological monitoring of exposure to 1,5-naphthalene diisocyanate and 4,4'-methylenediphenyl diisocyanate.

Authors:  C J Sennbro; C H Lindh; C Mattsson; B A G Jönsson; H Tinnerberg
Journal:  Int Arch Occup Environ Health       Date:  2006-02-28       Impact factor: 3.015

5.  Improvement in the GC-MS method for determining urinary toluene-diamine and its application to the biological monitoring of workers exposed to toluene-diisocyanate.

Authors:  Tadashi Sakai; Yoko Morita; Jaehoon Roh; Hyoungryoul Kim; Yangho Kim
Journal:  Int Arch Occup Environ Health       Date:  2005-05-26       Impact factor: 3.015

6.  Elimination kinetics of diisocyanates after specific inhalative challenges in humans: mass spectrometry analysis, as a basis for biomonitoring strategies.

Authors:  Lygia T Budnik; Dennis Nowak; Rolf Merget; Catherine Lemiere; Xaver Baur
Journal:  J Occup Med Toxicol       Date:  2011-03-29       Impact factor: 2.646

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.